In general, cancer incidence is projected to rise significantly, with global cases expected to increase by 20% by 2030 and ...

S&E bio Co., Ltd., a biotechnology company specializing in exosomal microRNA-based therapies, has received approval from Korea's Ministry of Food and Drug Safety (MFDS) to initiate a Phase 1b clinical ...

Fermenta Biotech Limited (Fermenta) proudly steps into its 75th year, beginning a momentous chapter in its journey of trust, ...

Pharma Industry Experts Come Together to Help Shape the Future of AI ...

T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety ...

Researchers from the Sant Pau Research Institute (IR Sant Pau), in collaboration with Sant Pau Hospital and the Josep ...

The global Live Cell Imaging Market, valued at US$2.88 billion in 2024, is forecasted to grow at a robust CAGR of 8.68%, ...

Recognizing the shift in media consumption, the ICB T20 Bash embraces modern digital integration, ensuring fans can catch ...